Research in earlier phases or small trials include evaluation of GLP-1s for cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder and as add-on to insulin for type 1 diabetes
Impaired Pathway Flow Poor removal of homocysteine or adenosine may favor the reversible SAH-hydrolase reaction moving back toward SAH
This information could be valuable in the decision to proceed with RSI (93.5%) vs cancelling the case (3.5%)
Why patients choose InjectCo for GHK-Cu therapy Book your free GHK-Cu consultation
Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodrguez M, et al
Benefits: Supports overall health